entertainment -WSS

entertainment

author：comprehensive 2025-10-01 11:00:28 - browse：753

What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.

For more on what we cover, here are the year’s best CEOs; here are the worst; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： American woman, child freed after being kidnapped in Haiti last month

entertainment

WSS

PBM reforms clear House panel

Methadone doses haven’t kept up in the age of fentanyl

Man killed during FBI raid in connection with threats against Biden, other officials

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Wikipedia

entertainment

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A daunting task: navigating dual Medicare, Medicaid eligibility

As demand for Covid shots wanes, Moderna seeks its next success

Drastic changes should bring profitability, startup health insurers say

Malaria cases in Florida and Texas: Here’s what you need to know

In same hospitals, Black patients receive fewer opioids than white patients

Activists slam private health insurers over coverage restrictions

Ransomware attacks on hospitals: Study outlines patient impact

Sports medicine is finally prioritizing gender equality

Emergent cuts jobs, executive role in business shake

leisure time

For Cytokinetics, FDA rejection of heart drug would help, not hinder

David Sabatini, ex

Readout LOUD podcast: A CRISPR milestone, biotech mixology

PBM reforms clear House panel

U.K. considers world's first use of meningitis vaccine to address gonorrhea

The best solution to the drug shortages problem

hotspot

entertainment

focus

focus